July 12, 2018
Targovax and SOTIO announce first patient dosed in Phase I/II combination trial of ONCOS-102 with DCVAC
Media
July 12, 2018
New Preclinical Results on Onxeo’s AsiDNA™, First-in-Class DNA Repair Inhibitor, Point to Strong Synergy and Reversion of Tumor Resistance when combined to PARP inhibitors
July 12, 2018
Interim Report Q2 2018
July 11, 2018
Altimmune Appoints Mitchel Sayare as Executive Chairman of the Board, and Adds José Ochoa to Its Leadership Team as Chief Business Officer
July 05, 2018
Håkan Johansson to start as BONESUPPORT’s CFO at the end of 2018
July 03, 2018
Vicore Pharma and HealthCap create a leading drug development company focused on severe lung diseases
June 29, 2018
FDA APPROVES ZEPHYR ENDOBRONCHIAL VALVE FOR TREATING SEVERE EMPHYSEMA
June 27, 2018
Carisma Therapeutics Announces a $53 Million Series A Financing to Develop Novel CAR Macrophage Cellular Immunotherapy
June 26, 2018
BioClin Therapeutics Appoints Scott Myers as Chairman to its Board of Directors
June 25, 2018
Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer